Cambridge Investment Research Advisors
AVNS icon

Cambridge Investment Research Advisors’s Avanos Medical AVNS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,288
Closed -$294K – 2157
2018
Q3 		$294K Buy
4,288
+433
+11% +$27.9K ﹤0.01% 1811
2018
Q2 		$221K Buy
+3,855
New +$204K ﹤0.01% 1942

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cambridge Investment Research Advisors's AVNS Position: Q4 2018 in Review

Cambridge Investment Research Advisors sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 4,288 shares — an estimated $294K sold.

Cambridge Investment Research Advisors first reported a position in AVNS in Q2 2018 and held it in 2 quarters. The position peaked at $294K in Q3 2018. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Cambridge Investment Research Advisors reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 4,288 Avanos Medical shares in Q4 2018, an estimated $294K.
  • Cambridge Investment Research Advisors first reported a position in Avanos Medical in Q2 2018 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Avanos Medical position peaked at $294K in Q3 2018.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2018, filed 5 Feb 2019.